BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) officially announces the RenMice ® series, which includes a collection of independently developed, ...
Effect of the killing style of individual CAR T cells on the clinicopathological behavior of therapeutic products in the clinic. Initial results from a first in human dose escalation trial of a novel ...
BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully human antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results